AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
复制标题
DOI:
10.1016/j.juro.2017.04.101
复制
发表时间:
2017-10
期刊:
影响因子:
--
通讯作者:
Eggener S
中科院分区:
文献类型:
--
作者:
Fulgham PF;Rukstalis DB;Turkbey IB;Rubenstein JN;Taneja S;Carroll PR;Pinto PA;Bjurlin MA;Eggener S
We summarize the available data about the clinical and economic effectiveness of magnetic resonance imaging in the diagnosis and management of prostate cancer, and provide practical recommendations for its use in the screening, diagnosis, staging and surveillance of prostate cancer. A panel of clinicians with expertise in the diagnosis and management of prostate cancer evaluated the current published literature on the use and effectiveness of magnetic resonance imaging for this disease. When adequate studies were available for analysis, recommendations were made on the basis of data and when adequate studies were not available, recommendations were made on the basis of expert consensus. At this time the data support the use of magnetic resonance imaging in patients with a previous negative biopsy and ongoing concerns about increased risk of prostate cancer. The data regarding its usefulness for initial biopsy suggest a possible role for magnetic resonance imaging in some circumstances. There is currently insufficient evidence to recommend magnetic resonance imaging for screening, staging or surveillance of prostate cancer. Although it adds cost to the management of prostate cancer, magnetic resonance imaging offers superior anatomic detail, and the ability to evaluate cellular density based on water diffusion and blood flow based on contrast enhancement. Imaging targeted biopsy may increase the diagnosis of clinically significant cancers by identifying specific lesions not visible on conventional ultrasound. The clinical indications for the use of magnetic resonance imaging in the management of prostate cancer are rapidly evolving.
登录
查看更多内容
DOI:
10.1002/jmri.25372
发表时间:
2017-03
期刊:
Journal of magnetic resonance imaging : JMRI
影响因子:
--
作者:
Greer MD;Brown AM;Shih JH;Summers RM;Marko J;Law YM;Sankineni S;George AK;Merino MJ;Pinto PA;Choyke PL;Turkbey B
通讯作者:
Turkbey B
影响因子:
23.4
作者:
Pokorny, Morgan R.;De Rooij, Maarten;Thompson, Leslie C.
通讯作者:
Thompson, Leslie C.
影响因子:
3.3
作者:
Mazaheri, Yousef;Vargas, H. Alberto;Hricak, Hedvig
通讯作者:
Hricak, Hedvig
DOI:
10.1097/coc.0b013e31829a2954
发表时间:
2015-06-01
影响因子:
2.6
作者:
Bittner, Nathan;Merrick, Gregory S.;Adamovich, Edward
通讯作者:
Adamovich, Edward
DOI:
10.1016/j.urolonc.2013.08.006
发表时间:
2014-08
期刊:
Urologic oncology
影响因子:
--
作者:
Sonn GA;Margolis DJ;Marks LS
通讯作者:
Marks LS